Genetic characterization of avian metapneumovirus subtype C isolated from pheasants in a live bird market

2007 ◽  
Vol 128 (1-2) ◽  
pp. 18-25 ◽  
Author(s):  
Eun ho Lee ◽  
Min-Suk Song ◽  
Jin-Young Shin ◽  
Young-Min Lee ◽  
Chul-Joong Kim ◽  
...  
2016 ◽  
Vol 161 (5) ◽  
pp. 1315-1322 ◽  
Author(s):  
Waleemas Jairak ◽  
Supanat Boonyapisitsopa ◽  
Supassama Chaiyawong ◽  
Nutthawan Nonthabenjawan ◽  
Ratanaporn Tangwangvivat ◽  
...  

2011 ◽  
Vol 8 (1) ◽  
pp. 131 ◽  
Author(s):  
Trong Wisedchanwet ◽  
Manoosak Wongphatcharachai ◽  
Supanat Boonyapisitsopa ◽  
Napawan Bunpapong ◽  
Pravina Kitikoon ◽  
...  

2021 ◽  
Vol 8 (10) ◽  
pp. 206
Author(s):  
Van-Giap Nguyen ◽  
Hee-Chun Chung ◽  
Hai-Quynh Do ◽  
Thanh-Trung Nguyen ◽  
Thi-Bich-Phuong Cao ◽  
...  

Avian Metapneumovirus (aMPV) is a causative agent of respiratory disease complex in turkeys and chickens that has recently been detected in Vietnam. Due to its novelty, this study was conducted to elucidate the distribution of aMPV in several provinces in northern Vietnam. By the application of Enzyme-Linked Immunosorbent Assay (ELISA) and nested Reverse Transcription-Polymerase Chain Reaction (RT-PCR), this study demonstrated the circulation of aMPV in 12 out of 14 cities/provinces with positive rates of 37.6% and 17.2%, respectively. All nested RT-PCR positive samples were aMPV subgroup B. By pairing the detection results with age groups, it was observed that aMPV infections occurred in chickens of all ages. Additionally, by genetic characterization, aMPV strains were demonstrated to not be attenuated vaccine viruses and to belong to at least two genetic clades. Overall, the obtained results provided insights into the prevalence of aMPV and indicated a greater complexity of respiratory diseases in chickens in Vietnam.


2014 ◽  
Vol 45 (1) ◽  
Author(s):  
Shikai Sun ◽  
Feng Chen ◽  
Sheng Cao ◽  
Jiajia Liu ◽  
Wen Lei ◽  
...  

2016 ◽  
Vol 161 (10) ◽  
pp. 2829-2834 ◽  
Author(s):  
Federica Di Profio ◽  
Irene Melegari ◽  
Vittorio Sarchese ◽  
Serena Robetto ◽  
Giuseppe Marruchella ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A166-A166
Author(s):  
S FUJII ◽  
T KUSAKA ◽  
T KAIHARA ◽  
Y UEDA ◽  
T CHIBA ◽  
...  

2009 ◽  
Vol 221 (03) ◽  
Author(s):  
R Vagkopoulou ◽  
C Eckert ◽  
U Ungethüm ◽  
G Körner ◽  
M Stanulla ◽  
...  

Tick-borne encephalitis virus (TBEV) was isolated for the first time in Sweden in 1958 (from ticks and from 1 tick-borne encephalitis [TBE] patient).1 In 2003, Haglund and colleagues reported the isolation and antigenic and genetic characterization of 14 TBEV strains from Swedish patients (samples collected 1991–1994).2 The first serum sample, from which TBEV was isolated, was obtained 2–10 days after onset of disease and found to be negative for anti-TBEV immunoglobulin M (IgM) by enzyme-linked immunosorbent assay (ELISA), whereas TBEV-specific IgM (and TBEV-specific immunoglobulin G/cerebrospinal fluid [IgG/CSF] activity) was demonstrated in later serum samples taken during the second phase of the disease.


Sign in / Sign up

Export Citation Format

Share Document